Postpartum Depression

NCT ID: NCT05595512

Last Updated: 2022-10-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

73 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-01-30

Study Completion Date

2021-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Postpartum depression (PPD) is one of the most common psychiatric complications of pregnancy and postpartum. It is often defined as an episode of depressive disorder that occurs in the postpartum period. Evidence suggests that PPD has serious consequences on the quality of life of all family members, increases the risk for familial conflicts, leaving great negative effects on maternal-infant interaction. The aim of our study was to investigate and shed the light on the determinants of development of PPD mainly maternal age among women in Jordan. We also aimed at examining additional factors on prevalence of PPD and providing more information on PPD among Jordanian mothers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This was a retrospective descriptive cross-sectional study and included patients were those diagnosed to have PPD within 6 months of delivery at Jordan University hospital (JUH) in the period 1st of January 2014 to the 1st of March 2021, Amman, Jordan. Data was collected retrospectively from the electronic files, from the departments of obstetrics and gynecology and psychiatry JUH in patients, outpatient clinics, inpatients' files delivery room records. All data are electronic in the period of the study. Inclusion criteria; patients with confirmed diagnosis of PPD with complete clinical data and have no other psychiatric diseases. Exclusion criteria; patients with maternal blues, patients with a diagnosis of any other psychiatric diseases, cases of unconfirmed depression and those with missing data.

Main outcome measure was the number of patients who developed PPD within 6 months of childbirth in relation to age, parity and mode of delivery. We collected data of patients who were confirmed to have a diagnosis of postpartum depression by a consultant psychiatrist in the hospital who followed diagnostic criteria of the American psychiatric association11. Intellectual disability was not specifically assessed in our patients.

The variables and information collected for this study included age, parity, mode of delivery, body mass index (BMI) that was objectively measured routinely in our obstetric population. In addition, medications, chronic diseases, past history of depression, psychiatry, breast feeding, and any social or marital problems were also retrieved. Data related to antenatal complications like antepartum hemorrhage (APH), diabetes mellitus (DM), preeclampsia toxemia (PET), urinary tract infection (UTI)/pyelonephritis necessitated hospital admission, postpartum hemorrhage (PPH) with no need for blood transfusion, PPH with blood transfusion, emergency hysterectomy for bleeding, fetal outcome including nursery (good, term), neonatal intensive care unit (NICU) admission: preterm, hypoxemia/acidosis, birth trauma, congenital anomalies, fetal loss \[Intrauterine Fetal Death (IUFD), stillborn, neonatal\] were also obtained

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Development of Depression Postpartum

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Naser Al-Husban

depressive symptoms within 6 months of delivery

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with confirmed diagnosis of PPD
* with complete clinical data
* have no other psychiatric diseases

Exclusion Criteria

* patients with maternal blues
* patients with a diagnosis of any other psychiatric diseases
* cases of unconfirmed depression
* those with missing data.
Minimum Eligible Age

18 Years

Maximum Eligible Age

49 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Jordan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Naser Al-Husban

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

JUH obstetrics

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Quetiapine Versus Trazadone in Women With Postpartum Depression
NCT06546358 NOT_YET_RECRUITING EARLY_PHASE1
Social Media, Teen Moms and PPD
NCT01967394 COMPLETED NA